A comprehensive view of Novartis AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia Patent: NOVARTIS Files Application for 'Antibody drug conjugates and methods for making thereof'
Published: April 19, 2024 by Australian Government
Australia: Novartis Receives Patent for '2-azaspiro(3.4)octane derivatives as M4 agonists'
Published: April 19, 2024 by Australian Government
Australia Patent: Novartis Files Application for 'Use of an anti-P-selectin antibody'
Published: April 19, 2024 by Australian Government
Patent Issued for Protein solution formulation containing high concentration of an anti-VEGF antibody (USPTO 11945859)
Published: April 19, 2024 by Angiogenesis Daily
Patent Issued for Fibroblast growth factor-21-Fc fusion proteins (USPTO 11944664)
Published: April 19, 2024 by Obesity Daily News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count